Novel Drug Works Against Hepatitis C
(MedPage Today) — The investigational drug GS-7977 performed well against hepatitis C virus (HCV) in treatment-naive patients, with or without contributions from pegylated interferon and ribavirin, several studies showed.
Article printed from Gastroenterology Education and CPD for trainees and specialists: https://www.gastrotraining.com